MEDLIVE (02192) announced that on January 5, 2026, a total of 700,000 ordinary shares were issued to two directors of the Company who exercised their share options pursuant to the pre-IPO share option scheme adopted on March 29, 2021.
Additionally, on the same date, 230,000 ordinary shares were issued to one employee of the Company who exercised share options under the same pre-IPO share option scheme.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.